Bayer Corporation is a large biopharmaceutical and life sciences company. It lobbies Congress on health care and women’s health policy, pollinator health and pesticide rules, agriculture and biofuels (including the Renewable Fuel Standard), tariffs, and budget/appropriations matters. The filings show ongoing monitoring and engagement on these topics.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRIAN NAGLE
The latest disclosures for this client.
BAYER CORPORATION (CONSOLIDATED REPORT)
1ABAYER CORPORATION (CONSOLIDATED REPORT)
4AThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
BAYER CORPORATION (CONSOLIDATED REPORT)
ERICK LUTT
BAYER CORPORATION (CONSOLIDATED REPORT)
JIM TRAVIS
BAYER CORPORATION (CONSOLIDATED REPORT)
MICHAEL HOLLAND
BAYER CORPORATION (CONSOLIDATED REPORT)
MICHAEL PARRISH
BAYER CORPORATION (CONSOLIDATED REPORT)
STEPHANIE MURPHY
BAYER CORPORATION (CONSOLIDATED REPORT)
PETER STEHOUWER
BAYER CORPORATION (CONSOLIDATED REPORT)
ERICA CISCHKE
BAYER CORPORATION (CONSOLIDATED REPORT)
BAYER CORPORATION (CONSOLIDATED REPORT)
Q2BAYER CORPORATION (CONSOLIDATED REPORT)
Q1BAYER CORPORATION (CONSOLIDATED REPORT)
Q4BAYER CORPORATION (CONSOLIDATED REPORT)
3ABAYER CORPORATION (CONSOLIDATED REPORT)
Q3BAYER CORPORATION (CONSOLIDATED REPORT)
Q2BAYER CORPORATION (CONSOLIDATED REPORT)
Q1